Ours is a story of India’s resilient public health system and of everyone working together as team India to battle the pandemic
There is also a growing interest in whole generation sequencing (WGS)
Transformation to pure-play Innovative Medicines company nears completion
The companies will leverage their respective proprietary technology platforms
This newly launched institute will be the centre of excellence in the treatment of all cancers under a single roof.
NULIBRY is a first-in-class cPMP substrate replacement therapy to reduce the risk of mortality in patients with MoCD Type A.
Singapore presents great opportunities for the adoption of technology in healthcare and is open for investments
First and only biologic approved in the EU in patients with severe asthma with no phenotype or biomarker limitations
The campaign will also focus on providing doorstep TB screening services to facilitate diagnosis
The #pledgemyeyes initiative reached out to over 30 million people across the country and the website registered 3X more pledges compared to the present numbers
Subscribe To Our Newsletter & Stay Updated
